Immediate Impact
2 by Nobel laureates 16 from Science/Nature 56 standout
Citing Papers
Lipoprotein(a) and cardiovascular disease
2024 Standout
Multiple sclerosis
2023 Standout
Works of P Chin being referenced
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis - results of the placebo-controlled, double-blind, Phase III ORATORIO study
2015
Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).
1993
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| P Chin | 126 | 86 | 9 | 96 | 16 | 337 | |
| Qiuying Ma | 164 | 60 | 7 | 31 | 18 | 374 | |
| María García‐Barcina | 128 | 25 | 3 | 40 | 17 | 308 | |
| Fang Deng | 118 | 38 | 72 | 36 | 16 | 348 | |
| Daniel B. Harmon | 117 | 21 | 4 | 53 | 14 | 388 | |
| Jennifer Kurz | 265 | 27 | 10 | 51 | 15 | 406 | |
| Kirsty R. Greenow | 179 | 14 | 8 | 98 | 13 | 373 | |
| Federica Ferrante | 101 | 24 | 6 | 55 | 14 | 392 | |
| Yu Shi | 124 | 30 | 6 | 73 | 18 | 379 | |
| György Íllyés | 56 | 18 | 9 | 94 | 23 | 344 | |
| Sheena L. M. Ong | 156 | 17 | 6 | 127 | 17 | 380 |
All Works
Login with ORCID to disown or claim papers
Loading papers...